Anthropic wants to develop its own drugs
Anthropic, known for its coding tools and AI models, has made a bold move into drug development with the launch of Claude Science, an AI workbench aimed at scientists. This new platform integrates various tools and datasets into a single environment, generating figures and visuals to aid research. By entering the drug development arena, Anthropic aims to leverage its AI expertise to accelerate scientific discoveries, potentially revolutionizing how new medications are created. This strategic shift underscores the growing intersection of AI and pharmaceuticals, highlighting the transformative potential of AI in medical research.
Original Source
Read the full article at Theverge →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.